Tandem Diabetes Care News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.04.20	Tandem Diabetes Care Announces First Quarter 2020 Financial Results (Businesswire)
09.04.20	Tandem Diabetes Care to Announce First Quarter 2020 Financial Results on April 30, 2020 (Businesswire)
16.03.20	Tandem Diabetes Care Announces Security Incident with Five Employee Email Accounts (Businesswire)
02.03.20	Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller (Businesswire)
24.02.20	Tandem Diabetes Care Announces Fourth Quarter and Full Year 2019 Financial Results and 2020 Financial Guidance (Businesswire)
14.02.20	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
27.01.20	Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020 (Businesswire)
15.01.20	Tandem Diabetes Care Announces Commercial Launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States (Businesswire)
09.01.20	Tandem Diabetes Care Appoints New Executive Vice President of Strategy and Corporate Development (Businesswire)
13.12.19	Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology (Businesswire)
20.11.19	Tandem Diabetes Care Announces Health Canada Approval of t:slim X2 Insulin Pump with Basal-IQ Predictive Low-Glucose Suspend Technology (Businesswire)
01.11.19	2019 Beyond Type Run Team to Race the TCS New York City Marathon Using Basal-IQ Technology from Tandem Diabetes Care (Businesswire)
30.10.19	Tandem Diabetes Care Presents Positive Real-World Data from Pediatric Users of t:slim X2 Insulin Pump with Basal-IQ Technology at International Conference (Businesswire)
16.10.19	Tandem Diabetes Care Announces NEJM Publication of Landmark Study Demonstrating Increased Time-In-Range with the t:slim X2 Insulin Pump with Control-IQ Technology (Businesswire)
14.10.19	Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019 (Businesswire)
18.09.19	Tandem Diabetes Care Announces Publication of Real-world Basal-IQ Predictive Low Glucose Suspend Technology Data in Diabetes Technology and Therapeutics Journal (Businesswire)
29.08.19	Tandem Diabetes Care Announces Upcoming Conference Participation and Presentations (Businesswire)
01.08.19	Tandem Diabetes Care Announces Second Quarter 2019 Financial Results and Updated 2019 Financial Guidance (Businesswire)
01.08.19	Tandem Diabetes Care Announces No-Cost Software Updates for t:slim X2 Insulin Pump Customers in the United States (Businesswire)
19.07.19	Tandem Diabetes Care to Announce Second Quarter 2019 Financial Results on August 1, 2019 (Businesswire)
20.06.19	Tandem Diabetes Care Announces Upcoming Conference Presentation (Businesswire)
10.06.19	Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology (Businesswire)
07.06.19	Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions (Businesswire)
13.05.19	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
30.04.19	Tandem Diabetes Care Announces First Quarter 2019 Financial Results and Updated 2019 Financial Guidance (Businesswire)
16.04.19	Tandem Diabetes Care to Announce First Quarter 2019 Financial Results on April 30, 2019 (Businesswire)
07.03.19	Tandem Diabetes Care Approved as Insulin Pump Vendor for ADP in Ontario, Canada (Businesswire)
06.03.19	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
06.03.19	Tandem Diabetes Care Announces Plan to Use Remote Software Update Tool in Ongoing Clinical Trial (Businesswire)
26.02.19	Tandem Diabetes Care Announces Succession Plan for Chief Executive Officer and Board of Directors (Businesswire)
20.02.19	Tandem Diabetes Care Appoints New Senior Vice President to Drive Expansion of Digital Health and Information Technology Initiatives (Businesswire)
15.02.19	t:slim X2 Insulin Pump First to Receive New ACE Pump Classification by FDA (Businesswire)
21.01.19	Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019 (Businesswire)
03.01.19	Tandem Diabetes Care Announces Appointment of Rebecca Robertson as Board Member (Businesswire)
13.11.18	Tandem Diabetes Care to Present at the Credit Suisse Healthcare Conference (Businesswire)
12.11.18	Tandem Diabetes Care Honored in San Diego 2018 Top Workplaces Awards From San Diego Union-Tribune (Businesswire)
08.11.18	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
01.11.18	Tandem Diabetes Care Reports Third Quarter 2018 Financial Results (Businesswire)
17.10.18	Tandem Diabetes Care to Announce Third Quarter 2018 Financial Results on November 1, 2018 (Businesswire)
12.10.18	Tandem Diabetes Care Receives Health Canada Approval to Market t:slim X2 Insulin Pump (Businesswire)
25.09.18	Tandem Diabetes Care Increases 2018 Sales Guidance and Provides Estimated Third Quarter Sales Results (Businesswire)
12.09.18	Tandem Diabetes Care to Webcast Investor & Analyst Day on September 25, 2018 (Businesswire)
29.08.18	Tandem Diabetes Care to Present at the Baird Global Healthcare Conference (Businesswire)
17.08.18	Tandem Diabetes Care Announces Commercial Launch of t:slim X2 Insulin Pump with Basal-IQ Technology in the United States (Businesswire)
08.08.18	Tandem Diabetes Care Announces Full Repayment of Outstanding CRG Debt (Businesswire)
08.08.18	Tandem Diabetes Care Announces Publication of PROLOG Study Results in Diabetes Care Journal (Businesswire)
07.08.18	Tandem Diabetes Care Announces Closing of $115 Million Underwritten Public Offering of Common Stock (Businesswire)
03.08.18	Tandem Diabetes Care Announces Pricing of $100 Million Public Offering of Common Stock (Businesswire)
02.08.18	Tandem Diabetes Care Announces Proposed Underwritten Public Offering of Common Stock (Businesswire)
30.07.18	Tandem Diabetes Care Reports Second Quarter 2018 Financial Results (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Tandem Diabetes Care Inc

Aktien Top/Flop

Meistgelesene Nachrichten